Hanqing Chen

机构：Capital Medical University · ORCID：0000-0001-5442-2071

发表论文 136 篇 · 总被引 3316 次 · h-index 32

代表论文

• The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapy (2024 · iMeta · 被引 34)
• Potent prophylactic cancer vaccines harnessing surface antigens shared by tumour cells and induced pluripotent stem cells (2024 · Nature Biomedical Engineering · 被引 31)
• Oral nanoparticle therapy for inflammatory bowel disease by Paneth cell regulation and mucus layer remodeling (2025 · Matter · 被引 28)
• Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 Degradation (2025 · ACS Nano · 被引 18)
• Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine (2024 · Cell Reports Medicine · 被引 18)
• iMeta Conference 2024: Building an innovative scientific research ecosystem for microbiome and One Health (2024 · iMeta · 被引 18)